We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,830 hedge funds and large institutions have $168B invested in Johnson & Johnson in 2013 Q3 according to their latest regulatory filings, with 85 funds opening new positions, 679 increasing their positions, 867 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more first-time investments, than exits

New positions opened: 85 | Existing positions closed: 30

2% more funds holding

Funds holding: 1,7921,830 (+38)

4% more capital invested

Capital invested by funds: $162B → $168B (+$6.31B)

6% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $1.91B

1.07% less ownership

Funds ownership: 66.95%65.88% (-1.1%)

7% less funds holding in top 10

Funds holding in top 10: 649606 (-43)

22% less repeat investments, than reductions

Existing positions increased: 679 | Existing positions reduced: 867

Holders
1,830
Holders Change
+38
Holders Change %
+2.12%
% of All Funds
59.34%
Holding in Top 10
606
Holding in Top 10 Change
-43
Holding in Top 10 Change %
-6.63%
% of All Funds
19.65%
New
85
Increased
679
Reduced
867
Closed
30
Calls
$1.79B
Puts
$1.91B
Net Calls
-$121M
Net Calls Change
-$124M
Name Holding Trade Value Shares
Change
Change in
Stake
FFA
401
First Foundation Advisors
California
$24.3M +$433K +4,832 +2%
PRC
402
Platte River Capital
Colorado
$24.3M -$2.38M -26,570 -9%
Cambridge Investment Research Advisors
403
Cambridge Investment Research Advisors
Iowa
$24.2M +$612K +6,820 +3%
GIM
404
Greylin Investment Management
Virginia
$24.1M -$3.13M -34,870 -11%
MWNA
405
Marshall Wace North America
New York
$23.9M +$24.8M +275,967 New
EWM
406
Evercore Wealth Management
New York
$23.8M -$1.39M -15,479 -5%
FCIM
407
Fairview Capital Investment Management
California
$23.7M +$39.5K +440 +0.2%
SFM
408
Systematic Financial Management
New Jersey
$23.5M -$1.27M -14,200 -5%
DC
409
Deere & Company
Illinois
$23.4M +$675K +7,520 +3%
OC
410
Oppenheimer & Co
New York
$23.3M +$2.42M +26,945 +11%
SPC
411
Stewart & Patten Company
California
$23.2M -$1.08M -12,026 -4%
JCM
412
Janney Capital Management
Pennsylvania
$23.2M +$1.65M +18,345 +7%
ESBC
413
E.S. Barr & Co
Kentucky
$23M -$419K -4,669 -2%
Truist Financial
414
Truist Financial
North Carolina
$23M -$1.31M -14,558 -5%
B
415
Barings
North Carolina
$22.9M +$565K +6,300 +2%
PIM
416
Perkins Investment Management
Illinois
$22.8M -$547K -6,100 -2%
GJIC
417
Gamble Jones Investment Counsel
California
$22.6M -$372K -4,145 -2%
BCM
418
Bridgeway Capital Management
Texas
$22.3M +$5.35M +59,620 +30%
BPBT
419
Boston Private Bank & Trust
Massachusetts
$22.3M +$504K +5,619 +2%
VanEck Associates
420
VanEck Associates
New York
$22.3M -$4.29M -47,766 -16%
SAM
421
Securian Asset Management
Minnesota
$21.9M +$317K +3,532 +1%
PP
422
Palladium Partners
Virginia
$21.8M +$322K +3,590 +1%
CCM
423
Cadence Capital Management
Massachusetts
$21.6M +$14.1M +157,244 +171%
CDH
424
Charles D. Hyman
$21.5M -$634K -7,064 -3%
CCI
425
Columbus Circle Investors
$21.3M +$22.1M +245,879 New

JNJ Hedge Fund Activity: Q3 2013 in Review

1,830 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2013, worth a combined $168B — up 3.9% from $162B a quarter earlier.

Buyers outnumbered sellers: 85 funds opened new JNJ positions and 30 closed out — a net gain of 55 holders — while 679 added to existing stakes and 867 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $495M. The largest seller was Goldman Sachs, cutting an estimated $1.15B.

  • 1,830 institutional investors held Johnson & Johnson (JNJ) as of Q3 2013, up from 1,792 in Q2 2013.
  • Funds reported $168B of Johnson & Johnson stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 85 funds opened new Johnson & Johnson positions in Q3 2013 and 30 closed out, a net change of +55 holders.
  • The largest Johnson & Johnson buyer in Q3 2013 was JP Morgan Chase, an estimated $495M added.
  • The largest Johnson & Johnson seller in Q3 2013 was Goldman Sachs, an estimated $1.15B sold.

Based on aggregated 13F filings for Q3 2013.